Quadruplet Power: Elevating Multiple Myeloma Frontline Therapy With Anti-CD38 Antibodies
Webinar/Online
Monday, August 4, 2025 at 2:00pm ET - 2:45pm ET
Add this event to your calendar
Info
Topic
Join us for a live webinar where leading experts in multiple myeloma (MM) will take a tactical approach, reviewing and discussing key findings from the initiative and practical strategies to sustainably integrate process improvements into clinical workflows to support evidence-based use of quadruplet therapies in frontline MM management, with the goal of optimizing patient outcomes. Don't miss this opportunity to enhance your knowledge, ask top-of-mind questions, and harness new approaches to align frontline treatment selection with the latest clinical evidence for newly diagnosed patients with MM.
Credits Offered
This event offers
0.75 contact hours
to attendees.
Accreditation Info:
AANP.
Additional Information
Don't miss this opportunity to enhance your knowledge, ask top-of-mind questions, and harness new approaches to align frontline treatment selection with the latest clinical evidence for newly diagnosed patients with MM.
Speakers
Associate Professor Hematology and Medical Oncology
Winship Cancer Institute, Emory University
Atlanta, GA
Associate Professor of Medicine, Division of Hematology-Oncology
Director, Multiple Myeloma Program
Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP)
Co-Chair, Scientific Review Committee, VICC
Disease Team Lead, Plasma Cell Dyscrasias and